BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35626196)

  • 1. Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.
    Lee CU; Song W; Koo MJ; Boo Y; Chung JH; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeong J; Jeon S
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.
    Huttanus HM; Vu T; Guruli G; Tracey A; Carswell W; Said N; Du P; Parkinson BG; Orlando G; Robertson JL; Senger RS
    PLoS One; 2020; 15(8):e0237070. PubMed ID: 32822394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine Is a Potential Urinary Biomarker for Non-Invasive Detection of Bladder Cancer with Microscopic Hematuria.
    Lin H; Zhou Q; Wu W; Ma Y
    Onco Targets Ther; 2019; 12():11765-11775. PubMed ID: 32099383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of bladder cancer in neuro-urological patients in France: a nationwide study.
    Michel F; Cancrini F; Bensadoun H; Cussenot O; Guillot-Tantay C; Rouprêt M; Karsenty G; Phé V
    World J Urol; 2022 Aug; 40(8):1921-1927. PubMed ID: 35182207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association detection between genetic variants in the microRNA binding sites of toll-like receptors signaling pathway genes and bladder cancer susceptibility.
    Cheng S; Liu J; Zhang Y; Lin Y; Liu Q; Li H; Huang J; Zhang P
    Int J Clin Exp Pathol; 2014; 7(11):8118-26. PubMed ID: 25550860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glance at imaging bladder cancer.
    Salmanoglu E; Halpern E; Trabulsi EJ; Kim S; Thakur ML
    Clin Transl Imaging; 2018 Aug; 6(4):257-269. PubMed ID: 30456208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The haphazard approach to the early detection of asymptomatic renal cancer: results from a contemporary executive health programme.
    Feldstein MS; Rhodes DJ; Parker AS; Orford RR; Castle EP
    BJU Int; 2009 Jul; 104(1):53-6. PubMed ID: 19154476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility.
    Mason J; Hasnain Z; Miranda G; Gill K; Djaladat H; Desai M; Newton PK; Gill IS; Kuhn P
    Eur Urol Open Sci; 2021 Oct; 32():8-18. PubMed ID: 34667954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.
    Shkolyar E; Zhao Q; Mach KE; Teslovich NC; Lee TJ; Cox S; Skinner EC; Lu Y; Liao JC
    Urol Oncol; 2021 Aug; 39(8):497.e9-497.e15. PubMed ID: 33766467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method.
    Glukhov A; Potoldykova N; Taratkin M; Gordeev S; Polyakovsky K; Laukhtina E; Moschini M; Abufaraj M; Shariat SF; Sekacheva M; Enikeev D; Glybochko P
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33806392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population.
    Kang M; Lee S; Jeong SJ; Hong SK; Byun SS; Lee SE; Jeong CW
    Int J Urol; 2015 Apr; 22(4):389-93. PubMed ID: 25581719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
    Martini A; Lonati C; Montorsi F; Briganti A; Colombo R; Necchi A; Simeone C; Zamboni S; Afferi L; Mattei A; Carando R; Ploussard G; Soria F; Marra G; Rouprêt M; Xylinas E; Pradere B; Abufaraj M; D'Andrea D; Shariat SF; Moschini M
    Clin Genitourin Cancer; 2022 Jun; 20(3):e190-e198. PubMed ID: 35105509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer.
    Moschini M; Karnes RJ; Suardi N; Bianchi M; Pellucchi F; Rocchini L; Damiano R; Serretta V; Salonia A; Montorsi F; Briganti A; Colombo R
    Clin Genitourin Cancer; 2016 Jun; 14(3):e245-50. PubMed ID: 26382220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural alterations of sugar chains in urine fibronectin from bladder cancer patients and its enzymatic mechanism.
    Guo JM; Zhang XY; Chen HL; Wang GM; Zhang YK
    J Cancer Res Clin Oncol; 2001 Aug; 127(8):512-9. PubMed ID: 11501752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.
    Anastasi E; Maggi M; Tartaglione S; Angeloni A; Gennarini G; Leoncini PP; Sperduti I; Di Lascio G; De Stefano V; Di Pierro GB; Del Giudice F; Busetto GM; De Berardinis E; Sciarra A
    Diagn Cytopathol; 2020 Nov; 48(11):1034-1040. PubMed ID: 32562513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
    Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
    Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.